Madrigal Pharmaceuticals (MDGL) Current Leases (2019 - 2025)
Historic Current Leases for Madrigal Pharmaceuticals (MDGL) over the last 13 years, with Q3 2025 value amounting to $1.1 million.
- Madrigal Pharmaceuticals' Current Leases rose 2334.85% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 2334.85%. This contributed to the annual value of $983000.0 for FY2024, which is 8652.75% up from last year.
- Madrigal Pharmaceuticals' Current Leases amounted to $1.1 million in Q3 2025, which was up 2334.85% from $1.0 million recorded in Q2 2025.
- Madrigal Pharmaceuticals' Current Leases' 5-year high stood at $1.1 million during Q3 2025, with a 5-year trough of $320000.0 in Q1 2021.
- In the last 5 years, Madrigal Pharmaceuticals' Current Leases had a median value of $557000.0 in 2024 and averaged $652894.7.
- In the last 5 years, Madrigal Pharmaceuticals' Current Leases skyrocketed by 11811.41% in 2022 and then crashed by 5324.23% in 2023.
- Madrigal Pharmaceuticals' Current Leases (Quarter) stood at $410000.0 in 2021, then skyrocketed by 46.83% to $602000.0 in 2022, then dropped by 12.46% to $527000.0 in 2023, then soared by 86.53% to $983000.0 in 2024, then increased by 10.17% to $1.1 million in 2025.
- Its Current Leases stands at $1.1 million for Q3 2025, versus $1.0 million for Q2 2025 and $1.0 million for Q1 2025.